🚨 Stop what you are doing and check out this stock 🚨

Jeff Bishop has an incredible new idea to talk to you about today… --------------------------------------------------------------- *Sponsored by Awareness Consulting Group, please see disclosures below. The market has been on FIRE the last couple of weeks! 🔥 As I look for new ideas to get into, one of the most interesting sectors I see right now is with Biotechs. Take a look at the Biotech ETF (IBB) below. See how it has been drifting lower most of this year, but just recently started to perk up?  A ran a scan using my custom charting patterns, and you can see that it has been a few months since we have seen such a strong, bullish indicator as we are right now. While most other sectors, like tech stocks, have already gotten ahead of themselves – I think Biotechs present a great opportunity right now. By the way, the last little biotech stock I talked about last week? It made a 45% move higher after I told you about it. I only bring that up to show you that there are some amazing opportunities out there right now if you know where to look. That leads me to the idea I want to share with you today – Mainz Biomed (MYNZ). This is a $6 stock that I believe has enormous potential right now. Have you ever seen those “Cologuard” commercials on TV?  You know, this little annoying character talking to you about why you should screen for colon cancer? (By the way… you SHOULD get a screening done…) Well, this cute little mascot has helped the parent company (EXAS) make a fortune in early-detection kits… 💰 (1) It’s so successful in fact, that it has become the first $1 BILLION diagnostic test kit on the market. (2) And this relatively simple test kit has helped EXAS shareholders witness some incredible returns the last few years, take a look: Right now, EXAS has a stranglehold on this huge market with no other viable competitors…at least yet! 👉👉👉 This is where MYNZ comes into the picture. 👈👈👈 MYNZ is aiming to launch the first viable competitor for Cologuard. I mean, this is a huge opportunity right now. I could try to explain it all, but MYNZ does a much better job of that!  Just look at some of the materials I clipped from their website (3). MYNZ isn’t just a start-up idea. They are well along the journey in their attempt to bring this to market. In fact, it is already available in Europe, and they are currently in an enrollment process for their US application.  MYNZ says they even expect the results in the first half of this year (not too far away!) (4) 🤞 The enormous potential for this global market is probably why analysts are drooling over the stock.  Look at the average projections that the Wall Street Journal has for MYNZ… (5) SeekingAlpha is roughly the same. They show the average analyst has a target that is 218% higher than the current price! (6) TipRanks shows that two analysts just reiterated their forecasts in the past week… (7) Seeking Alpha also has a great article detailing why MYNZ is a great long-term bet on testing kits (8)… I think one of the best things MYNZ did was take advantage of favorable terms for financing by raising over $22 MILLION when the stock was trading more than double the price it is today. (9) That move helped them secure a strong balance sheet with over $26 MILLION cash on hand (the figure below is reported by Yahoo Finance from their last filing date) (10) And again, from the MYNZ website, you can see they look a lot more promising than most early-stage biotech companies out there: One of my favorite technical trading sites, Tickeron, has this great report on what has happened with the stock historically when we have seen trading patterns like we see right now (11)… Bullish Trend Analysis The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 18 of 21 cases where MYNZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend 86%. Following a +3.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where MYNZ advanced for three days, in 50 of 59 cases, the price rose further within the following month. The odds of a continued upward trend 85%. I’ll follow up later with more information, but I hope this is a great start in helping you get up to speed on what MYNZ is all about. I sincerely think that this is an incredible story with huge potential ahead. If MYNZ is successful in their plans, this is a monster of an opportunity. At the current low valuation levels, I think this is definitely an idea that you need to check out right now! Of course, every company has its own set of unique risks that come along with the potential for gains. It’s important that you understand the good and bad, so get started by [visiting their website]( and do your own research. I think once you spend some time looking into this more, you will feel the same way I do! To Your Success, *Please see disclosures below Sources: - [( - [( - [( - [( - [( - [( - [( - [( - [( - [ - [ RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Manage your email subscriptions.]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Jason Bond Picks you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at JasonBondPicks.com. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.